Eflornithine + Nifurtimox Late-Stage Human African Trypanosomiasis (HAT)in West Nile, Uganda
Status:
Terminated
Trial end date:
1969-12-31
Target enrollment:
Participant gender:
Summary
This case series study follows on a terminated randomised clinical trial in a nearby location
of Uganda, in which the combination of eflornithine + nifurtimox showed very promising
efficacy and safety. The study's purpose is to evaluate the efficacy and safety of this
combination in a larger group of late-stage Human African trypanosomiasis (sleeping sickness)
patients.